Related Experiment Video
Updated: May 25, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Microalbuminuria is an independent prognostic marker in patients with chronic heart failure
Humberto Villacorta1, Paula de Vilhena Ferradaes, Evandro Tinoco Mesquita
1Curso de Pós-Graduação em Ciências Cardiovasculares, Universidade Federal Fluminense, Niterói, RJ, Brazil. hvillacorta@cardiol.br
Background:
Microalbuminuria has been described as a risk factor for progressive cardiovascular and renal diseases. Little is known about its prognostic value in patients (pts) with established heart failure (HF).
Objective:
To assess the role of microalbuminuria as a prognostic marker in patients with chronic HF receiving standard medication.
Methods:
From January 2008 through September 2009, 92 pts with chronic HF, were prospectively included. Mean age was 63.7 ± 12.2 and 37 (40.7%) were male. Mean left ventricular ejection fraction (LVEF) was 52.5 ± 17.5%. Pts under dialysis were excluded. Urinary albumin concentration (UAC) was determined in first morning spot sample of urine. Time to first event (HF hospitalization, emergency department visit for HF or cardiovascular death) was defined as endpoint. Mean follow-up was 11 ± 6.1 months.
Results:
At the time of inclusion in the study, 38 (41.3%) pts had microalbuminuria and no patient had overt albuminuria. Pts with microalbuminuria had lower left ventricular ejection fraction than the rest of the individuals (47.9 ± 18.5 vs 54.5 ± 17.7%, p=0.08). UAC was higher in patients with events (median 59.8 vs 18 mg/L, p=0.0005). Event-free survival was lower in pts with microalbuminuria as compared with normoalbuminuria (p<0.0001). Independent variables related to cardiac events were UAC (p<0.0001, hazard ratio=1.02, 95% CI=1.01 to 1.03 per 1-U increase of UAC), and previous myocardial infarction (p=0.025, HR=3.11, 95% CI=1.15 to 8.41).
Conclusion:
Microalbuminuria is an independent prognostic marker in pts with chronic HF. Pts with microalbuminuria had a trend for lower LVEF.
Insights
Microalbuminuria is an independent prognostic marker in patients with chronic heart failure (HF). Patients with microalbuminuria have a higher risk of cardiovascular events and mortality, indicating its clinical significance.
Area of Science:
- Cardiology
- Nephrology
- Clinical Research
Background:
- Microalbuminuria is a known risk factor for cardiovascular and renal diseases.
- Its prognostic value in patients with established heart failure (HF) is not well understood.
Purpose of the Study:
- To evaluate microalbuminuria as a prognostic marker in patients with chronic heart failure (HF).
- To assess its role in patients receiving standard HF medication.
Main Methods:
- Prospective study of 92 patients with chronic HF (mean age 63.7 years, 40.7% male).
- Urinary albumin concentration (UAC) measured in spot urine samples.
- Endpoint: HF hospitalization, ED visit for HF, or cardiovascular death; mean follow-up 11 months.
Main Results:
- 41.3% of patients had microalbuminuria; none had overt albuminuria.
- Microalbuminuria was associated with lower left ventricular ejection fraction (LVEF) (p=0.08).
- Higher UAC correlated with increased risk of cardiac events (p<0.0001) and lower event-free survival (p<0.0001).
Conclusions:
- Microalbuminuria is an independent predictor of adverse outcomes in chronic HF.
- Microalbuminuria may indicate a trend towards lower LVEF in HF patients.
Related Concept Videos
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management